Contact information
Sasha Maronova (preferred contact)
sasha.maronova@cmd.ox.ac.uk
https://orcid.org/0000-0002-8950-7646
NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ UK
Paul Brennan
PhD, FRSC
Professor of Medicinal Chemistry
- Director – Centre for Medicines Discovery
- Director of Chemistry – Chemical Probes Portal
My research group works at the interface of chemistry and biology to design probes and inhibitors to investigate the intricate workings of human proteins and cells, with particular interest in epigenetic proteins, small GTPases, and dementia. Research interests include medicinal chemistry, fragment- and structure-based drug design, computational chemistry, organic synthesis, and biochemistry. The group is part of the Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI), and Centre for AI in Precision Medicine at the University of Oxford.
More Information
Recent publications
DHODH is the key target of the KDM4 inhibitor QC6352 in glioblastoma stem cells.
Journal article
Sterling JR. et al, (2026), Nat Chem Biol
mBACS enhances pseudouridine profiling through efficient and robust chemical conversion
Preprint
Feng F. et al, (2026)
Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease
Journal article
Mazidi M. et al, (2026), JACC, 88, 1107 - 1120
Chemical probes for Alzheimer’s disease targets
Journal article
Aiken SG. et al, (2026), Essays in Biochemistry
Pleural fluid neutrophil extracellular traps are associated with disease severity and risk of 1-year mortality in pleural infection: an observational, international, multicohort study (TORPIDS-3)
Journal article
Chu JY. et al, (2026), European Respiratory Journal, 68, 2600113 - 2600113